{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T04:08:12Z","timestamp":1791518892284,"version":"4.3.4"},"reference-count":54,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T00:00:00Z","timestamp":1743724800000},"content-version":"am","delay-in-days":338,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.psychres.2024.115880","type":"journal-article","created":{"date-parts":[[2024,3,31]],"date-time":"2024-03-31T17:43:24Z","timestamp":1711907004000},"page":"115880","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review"],"prefix":"10.1016","volume":"335","author":[{"given":"B.","family":"Romeo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8090-0457","authenticated-orcid":false,"given":"E.","family":"Kervadec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3525-3334","authenticated-orcid":false,"given":"B.","family":"Fauvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9434-6226","authenticated-orcid":false,"given":"L.","family":"Strika-Bruneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Amirouche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V.","family":"Verroust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Piolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Benyamina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2024.115880_bib0001","doi-asserted-by":"crossref","DOI":"10.7759\/cureus.38669","article-title":"Cardiac arrest associated with psilocybin use and hereditary hemochromatosis","author":"Bae","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.psychres.2024.115880_bib0002","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.encep.2020.12.002","article-title":"Efficacit\u00e9 des psych\u00e9d\u00e9liques en psychiatrie, une revue syst\u00e9matique","volume":"47","author":"Berkovitch","year":"2021","journal-title":"L'Enc\u00e9phale"},{"key":"10.1016\/j.psychres.2024.115880_bib0003","first-page":"461","article-title":"Preliminary report on the effects of a low dose of LSD on resting-state amygdala functional connectivity","volume":"5","author":"Bershad","year":"2020","journal-title":"Biol. Psychiatry: Cognit. Neurosci. Neuroimag."},{"key":"10.1016\/j.psychres.2024.115880_bib0004","doi-asserted-by":"crossref","DOI":"10.1001\/jamapsychiatry.2022.2096","article-title":"Percentage of heavy drinking days Following psilocybin-assisted psychotherapy vs placebo in the treatment of adult patients with alcohol use disorder: a randomized clinical trial","author":"Bogenschutz","year":"2022","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1016\/j.psychres.2024.115880_bib0005","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1177\/02698811231215420","article-title":"Older adults in psychedelic-assisted therapy trials: a systematic review","volume":"38","author":"Bouchet","year":"2024","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2024.115880_bib0006","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s00213-017-4807-2","article-title":"Psilocybin disrupts sensory and higher order cognitive processing but not pre-attentive cognitive processing\u2014study on P300 and mismatch negativity in healthy volunteers","volume":"235","author":"Bravermanov\u00e1","year":"2018","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psychres.2024.115880_bib0007","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1177\/0269881120903465","article-title":"The serotonin 2A receptor agonist 25CN-NBOH increases murine heart rate and neck-arterial blood flow in a temperature-dependent manner","volume":"34","author":"Buchborn","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2024.115880_bib0008","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1177\/0269881116662634","article-title":"Survey study of challenging experiences after ingesting psilocybin mushrooms: acute and enduring positive and negative consequences","volume":"30","author":"Carbonaro","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2024.115880_bib0009","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1056\/NEJMoa2032994","article-title":"Trial of Psilocybin versus Escitalopram for depression","volume":"384","author":"Carhart-Harris","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psychres.2024.115880_bib0011","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","article-title":"Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis","volume":"391","author":"Cipriani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.psychres.2024.115880_bib0012","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv072","article-title":"Pharmacokinetics and concentration-effect relationship of oral LSD in humans","volume":"19","author":"Dolder","year":"2016","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2024.115880_bib0013","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1007\/s00213-011-2434-x","article-title":"Pharmacology of ayahuasca administered in two repeated doses","volume":"219","author":"dos Santos","year":"2012","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psychres.2024.115880_bib0014","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1097\/JCP.0000000000001428","article-title":"Ayahuasca Improves self-perception of speech performance in subjects with social anxiety disorder: a pilot, proof-of-concept, randomized, placebo-controlled trial","volume":"41","author":"dos Santos","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2024.115880_bib0015","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1177\/02698811211069103","article-title":"Safety, tolerability, pharmacokinetics, and subjective effects of 50, 75, and 100 \u00b5g LSD in healthy participants within a novel intervention paradigm: a proof-of-concept study","volume":"36","author":"Family","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2024.115880_bib0016","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1007\/s00213-019-05417-7","article-title":"Safety, tolerability, pharmacokinetics, and pharmacodynamics of low dose lysergic acid diethylamide (LSD) in healthy older volunteers","volume":"237","author":"Family","year":"2020","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psychres.2024.115880_bib0017","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s10072-017-2893-x","article-title":"Headache and arterial hypertension","volume":"38","author":"Finocchi","year":"2017","journal-title":"Neurol. Sci."},{"key":"10.1016\/j.psychres.2024.115880_bib0018","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1097\/NMD.0000000000000113","article-title":"Safety and efficacy of lysergic acid diethylamide-assisted psychotherapy for anxiety associated with life-threatening diseases","volume":"202","author":"Gasser","year":"2014","journal-title":"J. Nervous Mental Dis."},{"key":"10.1016\/j.psychres.2024.115880_bib0019","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJMoa2206443","article-title":"Single-dose psilocybin for a treatment-resistant episode of major depression","volume":"387","author":"Goodwin","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.psychres.2024.115880_bib0020","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1177\/0269881116675513","article-title":"Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: a randomized double-blind trial","volume":"30","author":"Griffiths","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2024.115880_bib0021","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/0269881117731279","article-title":"Psilocybin-occasioned mystical-type experience in combination with meditation and other spiritual practices produces enduring positive changes in psychological functioning and in trait measures of prosocial attitudes and behaviors","volume":"32","author":"Griffiths","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2024.115880_bib0022","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00213-011-2358-5","article-title":"Psilocybin occasioned mystical-type experiences: immediate and persisting dose-related effects","volume":"218","author":"Griffiths","year":"2011","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psychres.2024.115880_bib0023","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1007\/s00213-006-0457-5","article-title":"Psilocybin can occasion mystical-type experiences having substantial and sustained personal meaning and spiritual significance","volume":"187","author":"Griffiths","year":"2006","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psychres.2024.115880_bib0024","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/archgenpsychiatry.2010.116","article-title":"Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer","volume":"68","author":"Grob","year":"2011","journal-title":"Arch. Gen. Psychiatry"},{"key":"10.1016\/j.psychres.2024.115880_bib0025","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbr.2014.07.016","article-title":"Recent advances in the neuropsychopharmacology of serotonergic hallucinogens","volume":"277","author":"Halberstadt","year":"2015","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.psychres.2024.115880_bib0026","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s00213-003-1640-6","article-title":"Acute psychological and physiological effects of psilocybin in healthy humans: a double-blind, placebo-controlled dose? Effect study","volume":"172","author":"Hasler","year":"2004","journal-title":"Psychopharmacology (Berl.)"},{"key":"10.1016\/j.psychres.2024.115880_bib0027","series-title":"Cochrane Handbook for Systematic Reviews of Interventions 4.2.6","author":"Higgins","year":"2006"},{"key":"10.1016\/j.psychres.2024.115880_bib0028","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.biopsych.2022.08.025","article-title":"Lysergic Acid diethylamide\u2013assisted therapy in patients with anxiety with and without a life-threatening Illness: a randomized, double-blind, placebo-controlled phase II study","volume":"93","author":"Holze","year":"2023","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2024.115880_bib0029","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1038\/s41386-022-01297-2","article-title":"Direct comparison of the acute effects of lysergic acid diethylamide and psilocybin in a double-blind placebo-controlled study in healthy subjects","volume":"47","author":"Holze","year":"2022","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2024.115880_bib0030","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/s41386-020-00883-6","article-title":"Acute dose-dependent effects of lysergic acid diethylamide in a double-blind placebo-controlled study in healthy subjects","volume":"46","author":"Holze","year":"2021","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2024.115880_bib0031","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/s41386-019-0569-3","article-title":"Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects","volume":"45","author":"Holze","year":"2020","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2024.115880_bib0032","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.ejphar.2013.10.014","article-title":"Looking beyond 5-HT3 receptors: a review of the wider role of serotonin in the pharmacology of nausea and vomiting","volume":"722","author":"Johnston","year":"2014","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.psychres.2024.115880_bib0033","doi-asserted-by":"crossref","DOI":"10.1038\/s41386-023-01607-2","article-title":"Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants","author":"Ley","year":"2023","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.psychres.2024.115880_bib0034","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med."},{"key":"10.1016\/j.psychres.2024.115880_bib0035","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1038\/nn.2723","article-title":"from reinforcement learning models to psychiatric and neurological disorders","volume":"14","author":"Maia","year":"2011","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.psychres.2024.115880_bib0036","doi-asserted-by":"crossref","DOI":"10.1111\/psyp.13822","article-title":"LSD and ketanserin and their impact on the human autonomic nervous system","volume":"58","author":"Olbrich","year":"2021","journal-title":"Psychophysiology"},{"key":"10.1016\/j.psychres.2024.115880_bib0037","doi-asserted-by":"crossref","DOI":"10.1016\/j.pnpbp.2021.110266","article-title":"Gastrointestinal side effects associated with antidepressant treatments in patients with major depressive disorder: a systematic review and meta-analysis","volume":"109","author":"Oliva","year":"2021","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2024.115880_bib0038","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1017\/S0033291718001356","article-title":"Rapid antidepressant effects of the psychedelic ayahuasca in treatment-resistant depression: a randomized placebo-controlled trial","volume":"49","author":"Palhano-Fontes","year":"2019","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2024.115880_bib0039","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1080\/1355621021000005937","article-title":"The pharmacology of psilocybin","volume":"7","author":"Passie","year":"2002","journal-title":"Addict. Biol."},{"key":"10.1016\/j.psychres.2024.115880_bib0040","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/JCP.0000000000001396","article-title":"Effects of ayahuasca on the recognition of facial expressions of emotions in naive healthy volunteers: a pilot, proof-of-concept, randomized controlled trial","volume":"41","author":"Rocha","year":"2021","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.psychres.2024.115880_bib0041","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1177\/0269881120919957","article-title":"Efficacy of psychedelic treatments on depressive symptoms: a meta-analysis","volume":"34","author":"Romeo","year":"2020","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2024.115880_bib0042","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1177\/0269881116675512","article-title":"Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial","volume":"30","author":"Ross","year":"2016","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2024.115880_bib0043","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/02698811211064720","article-title":"The effects of psilocybin on cognitive and emotional functions in healthy participants: results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation","volume":"36","author":"Rucker","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2024.115880_bib0044","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1176\/ajp.2006.163.11.1905","article-title":"Acute and longer-term Outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report","volume":"163","author":"Rush","year":"2006","journal-title":"AJP"},{"key":"10.1016\/j.psychres.2024.115880_bib0045","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1007\/s13311-020-00962-y","article-title":"Exploratory controlled study of the migraine-suppressing effects of psilocybin","volume":"18","author":"Schindler","year":"2021","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.psychres.2024.115880_bib0046","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1111\/head.14420","article-title":"Exploratory investigation of a patient-informed low-dose psilocybin pulse regimen in the suppression of cluster headache: results from a randomized, double-blind, placebo-controlled trial","volume":"62","author":"Schindler","year":"2022","journal-title":"Headache"},{"key":"10.1016\/j.psychres.2024.115880_bib0047","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/02698811211069100","article-title":"Adverse effects of psychedelics: from anecdotes and misinformation to systematic science","volume":"36","author":"Schlag","year":"2022","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2024.115880_bib0048","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1016\/j.biopsych.2014.11.015","article-title":"Acute effects of lysergic acid diethylamide in healthy subjects","volume":"78","author":"Schmid","year":"2015","journal-title":"Biol. Psychiatry"},{"key":"10.1016\/j.psychres.2024.115880_bib0049","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.mehy.2012.09.021","article-title":"Early relapse in alcohol dependence may result from late withdrawal symptoms","volume":"79","author":"Simioni","year":"2012","journal-title":"Med. Hypotheses"},{"key":"10.1016\/j.psychres.2024.115880_bib0050","doi-asserted-by":"crossref","first-page":"469","DOI":"10.15288\/qjsa.1966.27.469","article-title":"A controlled study of lysergide in the treatment of alcoholism. I . The effects on drinking behavior","volume":"27","author":"Smart","year":"1966","journal-title":"Q. J. Stud. Alcohol"},{"key":"10.1016\/j.psychres.2024.115880_bib0051","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1017\/S0033291723003653","article-title":"Assessing expectancy and suggestibility in a trial of Escitalopram v. Psilocybin for depression","author":"Szigeti","year":"2024","journal-title":"Psychol. Med."},{"key":"10.1016\/j.psychres.2024.115880_bib0052","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1592\/phco.29.7.822","article-title":"Pharmacogenetics of selective serotonin reuptake inhibitors and associated adverse drug reactions","volume":"29","author":"Thomas","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.psychres.2024.115880_bib0053","article-title":"Single-dose psilocybin-assisted therapy in major depressive disorder: a placebo-controlled, double-blind, randomised clinical trial","volume":"56","author":"von Rotz","year":"2023","journal-title":"eClinicalMedicine"},{"key":"10.1016\/j.psychres.2024.115880_bib0054","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1021\/acsptsci.1c00024","article-title":"On the Relationship between classic psychedelics and suicidality: a systematic review","volume":"4","author":"Zeifman","year":"2021","journal-title":"ACS Pharmacol. Transl. Sci."},{"key":"10.1016\/j.psychres.2024.115880_bib0055","article-title":"Decreases in suicidality following psychedelic therapy: a meta-analysis of individual patient data across clinical trials","volume":"83","author":"Zeifman","year":"2022","journal-title":"J. Clin. Psychiatry"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178124001653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178124001653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,4,25]],"date-time":"2024-04-25T16:30:50Z","timestamp":1714062650000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178124001653"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":54,"alternative-id":["S0165178124001653"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2024.115880","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2024.115880","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115880"}}